Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;51(7):739-740.
doi: 10.1016/j.arcmed.2020.06.009. Epub 2020 Jun 12.

Amantadine Treatment for People with COVID-19

Ramiro Araújo  1 , José Dolores Aranda-Martínez  2 , Gonzalo Emiliano Aranda-Abreu  3
Affiliations

Amantadine Treatment for People with COVID-19

Ramiro Araújo et al. Arch Med Res. 2020 Oct.

Abstract

SARS-Cov-2, whose symptoms include difficulty swallowing, coughing, diarrhea, and breathing failure, has caused the loss of many lives around the world. In the absence of a vaccine or medication to help prevent or decrease the effects of the disease, we suggest that amantadine may reduce the effects of COVID-19.

Keywords: Amantadine; COVID-19; Drugs.

PubMed Disclaimer

Comment in

  • Amantadine, COVID-19 and Parkinsonism.
    Wiwanitkit V. Wiwanitkit V. Arch Med Res. 2020 Oct;51(7):714. doi: 10.1016/j.arcmed.2020.07.001. Epub 2020 Jul 3. Arch Med Res. 2020. PMID: 32660794 Free PMC article. No abstract available.

References

    1. Gautret P., Lagier J.-C.H., Parola P. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949. - PMC - PubMed
    1. Molina J.M., Delaugerre C., Le Goff J. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. [letter] Med Mal Infect. 2020;50:384. - PMC - PubMed
    1. Borba M.G.S., Almeida Val F.F., Sampaio V. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open. 2020;3:e208857. - PMC - PubMed
    1. Rejdak K., Grieb PRejdak K., Grieb P. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment. Mult Scler Relat Disord. 2020;42:102163. - PMC - PubMed
    1. Smieszek S.P., Przychodzen B.P., Polymeropoulos M.H. Amantadine disrupts lysosomal gene expression: a hypothesis for COVID19 treatment. Int J Antimicrob Agents. 2020:106004. - PMC - PubMed